A liver-targeting active compound having the general formula (I):
wherein A is α-OH or β-OH, B is α-H or β-H, C is —H, α-OH or β-OH, or B and C together form a double bond, D is —H, α-OH or β-OH, E is —H, α-OH or β-OH, -G- is a side chain moiety, —NH-J is selected from (i) a residue of an amino group-containing active compound wherein said —NH— group is provided by said amino group of the active compound, and (ii) a residue of an active compound to which an amino group has been added wherein said —NH— group is provided by said added amino group; each of X and Y independently represents a single bond, —(CH,
2
)
z
— (where z is 1 to 8), —O— or —S—; n is 0 or 1; m is 0 or 1; and p is 0 or 1; provided that, when —NH-J is (i), m is 1. A method of producing such a compound is also disclosed.
一种具有通式(I)的以肝脏为靶点的活性化合物:其中A为α-OH或β-OH,B为α-H或β-H,C为-H、α-OH或β-OH,或B和C一起形成双键,D为-H、α-OH或β-OH,E为-H、α-OH或β-OH,-G-为侧链基团,—NH-J选择自(i)含有
氨基活性化合物的残基,其中所述—NH—基团由所述活性化合物的
氨基提供,和(ii)添加了
氨基的活性化合物的残基,其中所述—NH—基团由所述添加的
氨基提供;每个X和Y独立表示单键,—(CH,2)z—(其中z为1至8),—O—或—S—;n为0或1;m为0或1;p为0或1;但当—NH-J为(i)时,m为1。还公开了一种制备这种化合物的方法。